U.S. Markets closed

Lifshitz & Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience, Inc., Novan, Inc., Regulus Therapeutics Incs., The Southern Company and The Western Union Company

NEW YORK, Feb. 17, 2017 /PRNewswire/ --

Aetna Inc. (AET)

Lifshitz & Miller announces investigation on behalf of AET investors concerning AET's abandoned acquisition of Humana Inc.

If you are an AET investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

GenVec, Inc. (GNVC)

Lifshitz & Miller  announces an investigation into possible breaches of fiduciary duties by the board of directors of GNVC in connection with the sale of GNVC to Intrexon Corporation for 0.297 Intrexon shares per GNVC share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Ixia (XXIA)

Lifshitz & Miller  announces an investigation into possible breaches of fiduciary duties by the board of XXIA in connection with the sale of XXIA to Keysight Technologies, Inc. for $19.64 per share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

McKesson Corporation (MCK)

Lifshitz & Miller announces investigation on behalf of MCK investors concerning MCK's monitoring and distribution of prescription painkillers.

If you are an MCK investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Meridian Bioscience, Inc. (VIVO)

Lifshitz & Miller announces investigation on behalf of VIVO investors concerning the downward adjustment of VIVO's 2017 revenue forecast.

If you are a VIVO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Novan, Inc. (NOVN)

Lifshitz & Miller announces investigation on behalf of NOVN investors concerning NOVN's topical acne treatment clinical trials.

If you are an NOVN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Regulus Therapeutics Inc. (RGLS)

Lifshitz & Miller announces investigation on behalf of RGLS investors concerning the safety of its hepatitis treatment.

If you are an RGLS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

The Southern Company (SO)

Lifshitz & Miller announces investigation on behalf of SO investors concerning the completion progress of the Kemper Plant.

If you are an SO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

The Western Union Company (WU)

Lifshitz & Miller announces investigation on behalf of WU investors concerning the effectiveness of WU's anti-money laundering program.

If you are a WU investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP. The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780 
Facsimile: 516-280-7376
Email:
info@jlclasslaw.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-aetna-inc-genvec-inc-ixia-mckesson-corporation-meridian-bioscience-inc-novan-inc-regulus-therapeutics-incs-the-southern-company-and-the-western-union-company-300409655.html